C alcium (Ca
) is an important component of signal transduction, but uncontrolled Ca 2+ influx, such as occurs during ischemia and epilepsy, can disrupt cellular homeostasis and lead to neuronal damage. 1 Recently, three subtypes of voltage-sensitive Ca 2+ channels have been found in the brain, namely T-, N-, and L-types. 2 Binding sites for 1,4-dihydropyridine drugs are associated with L-type Ca 2+ channels and are highly concentrated in the central nervous system, 3 with high binding activity in the hippocampus. 4 ' 5 There has been growing interest in the application of 1,4-dihydropyridine Ca channel blockers as protective agents against ischemic brain damage. 6 -8 Selective hippocampal pyramidal cell damage in the CAl occurs 1-2 days after ischemia, when minimal energy crises or morphologic changes (delayed neuronal death) are noticed. 9 Ischemic pyramidal cell death is commonly employed as a model for screening neuroprotective drugs. Although numerous studies have been designed to investigate the L-type Ca 2+ channel antagonists as potential therapeutic agents for ischemic neuronal injury, there has been no agreement as to their protective effect on CAl pyramidal cell damage. 7 -8 However, the stroke models and drug administration schedules have been quite different among these studies. We studied the temporal profile of L-type Ca 2+ channels in the rat hippocampus following transient forebrain ischemia by means of quantitative autoradiography using [ 3 H]PN200-110 (PN), a new dihydropyridine Ca 2+ channel blocker. 10 We also performed adenosine A, receptor and muscarinic cholinergic receptor autoradiography for comparison with the Ca 2+ antagonist binding sites.
Materials and Methods
We used 57 male Wistar rats weighing 220-280 g and induced transient forebrain ischemia in 49 of them using a slightly modified version of the method of Pulsinelli and Brierley 11 as described previously.
12
All rats were anesthetized with 50 mg/kg i.p. pentobarbital, and both vertebral arteries of each rat were electrocauterized. The next day, the common carotid arteries were exposed under 2% halothane anesthesia. In the 49 ischemic rats, 3 minutes after the halothane was discontinued both common carotid arteries were clamped for 20 minutes. The eight control rats were prepared and handled similarly, except their common carotid arteries were not clamped. The criteria used to judge the occurrence of ischemia are described elsewhere. 12 After 1 (rc=7), 3 (n=7), 6 (n=8), 12 (n=7), 24 (n=6), 48 (n=6), or 168 (n=8) hours of recirculation the rats were decapitated, and the brains were removed quickly and frozen in powdered dry ice. Coronal sections 12 ^,m thick were cut on a cryostat and thaw-mounted onto gelatin-coated slides. Adjacent sections were used for histopathology. The slides were dried under a stream of cold air and apposed to LKB Ultrofilm (Gaithersburg, Maryland) for 2-4 weeks. The optical density of the regions of interest was measured using an image analyzer system (MICD system, Imaging Research, Inc., St. Catharines, Canada). The relation between optical density and radioactivity was calculated using third-order polynomials with reference to tritium standards exposed along with the sections. Preliminarily, brain mash sections containing known amounts of radioactivity were apposed to Ultrofilm along with a tritium microscale (Amersham, Arlington Heights, Illinois), and the grain density correlation between the brain mash sections and the microscale was obtained. This microscale was used in our routine studies. Optical densities of the brain regions measured were within the range in which the optical density and the tritium microscale radioactivity showed a near-linear relation. No significant differences in nonspecific binding activity were observed between the control and ischemic rats (data not shown). As discussed in our previous study, 13 we did not correct for quenching after hippocampal lesioning due to ischemia.
The three binding assays were performed in duplicate. The groups were compared using the Mann-Whitney U test.
Results

CA1 pyramidal cells exhibited delayed neuronal death
912 " 14 after ischemia. They appeared intact by light microscopy 24 hours after ischemia, but by 48 hours some pyramidal cells were damaged. Most pyramidal cells were necrotic 72 hours after ischemia, and the populations were completely depleted by 168 hours (data not shown). CA3 pyramidal cells and dentate granule cells showed no visible damage by light microscopy at any time (data not shown).
There was a very high density of silver grains ([ (Table 2) , 13 with the highest densities in the strata oriens and radiatum. The dendritic fields of the CA3 subfield and the stratum moleculare of the dentate gyrus also showed high densities. is In the stratum oriens of the CA1 subfield, [ 3 H]PN binding decreased significantly after 3 hours of recirculation. Thus, neuronal activity of the CA1 pyramidal cells may be altered despite minimal morphologic damage early during recirculation. By 168 hours after ischemia, when the populations of CA1 pyramidal cells were depleted, approx- . However, the protective role of L-type Ca 2+ channel blockers is not specific but rather subsidiary. Ca 2+ antagonists have little effect on transmitter release. Ca 2+ antagonists administered both before and during ischemia have been shown to protect against CA1 pyramidal cell death. 7 In contrast, their administration after ischemia fails to prevent CA1 pyramidal cell death. 8 Our data should help reconcile these contradictory results. Since [ 3 H]PN binding was reduced after only 3 hours of recirculation in the CA1 subfield, postischemic administration of Ca 2+ antagonists may be much less effective than preischemic administration. Similarly, the decrease in [ 3 H]CHA binding early during recirculation also suggests that preischemic administration of adenosine agonists, which have been reported to prevent CA1 pyramidal cell death, may be more effective in protecting against CA1 damage. 17 We need well-controlled trials that pay particular attention to maintaining sufficient drug concentrations in target tissues during the early stages of recirculation, at which time the fate of CA1 pyramidal cells may be determined.
